CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 2.650
+0.050 (1.92%)
Apr 17, 2026, 4:08 PM HKT
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 1.55 billion as of April 17, 2026. Its market cap has increased by 2,395.96% in one year.
Market Cap
1.55B
Enterprise Value
1.49B
Revenue
55.62M
Ranking
n/a
PE Ratio
77.88
Stock Price
2.65
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 1.55B, a decrease of -58.99%. That is a compound annual growth rate of -18.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 1.55B | 18.32% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
| Dec 10, 2021 | 3.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 2.34B |
| Immunotech Biopharm | 2.21B |
| Frontage Holdings | 2.07B |
| HighTide Therapeutics | 2.05B |
| Mabpharm | 1.88B |
| Cutia Therapeutics | 1.71B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.69B |
| Zhaoke Ophthalmology | 1.67B |